|
|
|
Volumn 6, Issue 5, 2002, Pages 396-405
|
|
Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: Results from Tomsk, Siberia
a
a
a
a
a
a
a
|
|
Author keywords
Cost effectiveness analysis; Russian treatment; Short course chemotherapy; Tuberculosis
|
|
Indexed keywords
ABISIB;
ADENOSINE TRIPHOSPHATE;
CALCIUM CHLORIDE;
CHYMOTRYPSIN;
ETHAMBUTOL;
ETHIMIZOLE;
ISONIAZID;
LIDASE;
PREDNISOLONE;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
T ACTIVIN;
TIMALIN;
UNCLASSIFIED DRUG;
VITAMIN B GROUP;
ADULT;
ARTICLE;
ARTIFICIAL PNEUMOTHORAX;
BLOOD AUTOTRANSFUSION;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
HOSPITALIZATION;
HOUSEHOLD;
HUMAN;
LASER SURGERY;
LUNG RESECTION;
MAJOR CLINICAL STUDY;
MALE;
PLASMAPHERESIS;
PLEURA EMPYEMA;
PNEUMOPERITONEUM;
PRIORITY JOURNAL;
RUSSIAN FEDERATION;
SENSITIVITY ANALYSIS;
SHORT COURSE THERAPY;
SOCIETY;
THORAX SURGERY;
TREATMENT OUTCOME;
TUBERCULOSIS;
ULTRASOUND THERAPY;
WORLD HEALTH ORGANIZATION;
ADULT;
ANTITUBERCULAR AGENTS;
COST-BENEFIT ANALYSIS;
DIRECTLY OBSERVED THERAPY;
DRUG COSTS;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
MALE;
MIDDLE AGED;
SIBERIA;
SOCIAL CLASS;
TIME FACTORS;
TUBERCULOSIS;
|
|
EID: 0036254796
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (21)
|
|
References (24)
|
